Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Melosky%2C+Barbara+L%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Melosky%2C+Barbara+L%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Melosky%2C+Barbara+L%22&type=Person&sort=year
PubPharm (8)
1
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC
enthalten in:
Current oncology (Toronto, Ont.)
| 2023
von
Cheema, P.
|
Banerji, S.
|
Blais, N.
| +10
Wird geladen...
2
Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer
enthalten in:
Current oncology (Toronto, Ont.)
| 2023
von
Melosky, B.
|
Leighl, N.
|
Dawe, D.
| +9
Wird geladen...
3
Canadian Consensus Recommendations on the Management of MET-Altered NSCLC
enthalten in:
Current oncology (Toronto, Ont.)
| 2021
von
Cheema, P.
|
Banerji, S.
|
Blais, N.
| +7
Wird geladen...
4
A phase II trial of the effect of perindopril on hand-foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC
enthalten in:
Cancer chemotherapy and pharmacology
| 2019
von
Melosky, B.
|
Lim, H.
|
Davies, J.
| +5
Wird geladen...
5
A phase II trial of the effect of perindopril on hand–foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC
enthalten in:
Cancer chemotherapy and pharmacology
| 2018
von
Melosky, B.
|
Lim, H.
|
Davies, J.
| +5
Wird geladen...
6
A phase II trial of the effect of perindopril on hand–foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC
enthalten in:
Cancer chemotherapy and pharmacology
| 2018
von
Melosky, B.
|
Lim, H.
|
Davies, J.
| +5
Wird geladen...
7
A phase II trial of the effect of perindopril on hand–foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC
enthalten in:
Cancer chemotherapy and pharmacology
| 2018
von
Melosky, B.
|
Lim, H.
|
Davies, J.
| +5
Wird geladen...
8
Canadian Cancer Trials Group (CCTG) IND211 : A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2018
von
Bradbury, P.
|
Morris, D.
|
Nicholas, G.
| +22
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
8
Aufsätze
7
E-Artikel
7
E-Ressourcen
1
Gedruckte Aufsätze
Zeitschriftentitel
4
Cancer chemotherapy and pharmacology
3
Current oncology (Toronto, Ont.)
1
Lung cancer (Amsterdam, Netherlands)
Thema
5
Research Support, Non-U.S. Gov't
4
ACE inhibitor
4
Colorectal cancer
4
HFSR
4
Perindopril
4
Regorafenib
3
Guideline
3
Journal Article
2
Clinical Trial, Phase II
2
Protein Kinase Inhibitors
2
immune checkpoint inhibitors
1
04Q9AIZ7NO
1
15H5577CQD
1
24T2A1DOYB
1
Angiotensin-Converting Enzyme Inhibitors
1
Clinical trial
1
Docetaxel
1
EC 3.6.5.2
1
EGFR resistance
1
KRAS G12C
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3
2020-
5
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
8
Englisch
Haven't found what you're looking for?
Wird geladen...